Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder.
Comprehensive characterizations of bladder cancer (BCa) have established molecular phenotype classes with distinct alterations and survival trends. Extending these studies within the tyrosine kinase (TK) family to identify disease drivers could improve our use of TK inhibitors to treat specific pati...
Guardado en:
Autores principales: | Young H Lee, Molly M Lee, Dinuka M De Silva, Arpita Roy, Cara E Wright, Tiffany K Wong, Rene Costello, Oluwole Olaku, Robert L Grubb, Piyush K Agarwal, Andrea B Apolo, Donald P Bottaro |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5394fb87b5264fd6b4b74d104edefe1c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Expression of Spred2 in the urothelial tumorigenesis of the urinary bladder.
por: Shinsuke Oda, et al.
Publicado: (2021) -
Tumor-Associated Mast Cells in Urothelial Bladder Cancer: Optimizing Immuno-Oncology
por: Hae Woong Choi, et al.
Publicado: (2021) -
Bladder Recurrence Following the Treatment of Upper Tract Urothelial Carcinoma
por: Takarn Itsaranujareankul, et al.
Publicado: (2021) -
Oxidative status and lipofuscin accumulation in urothelial cells of bladder in aging mice.
por: Martina Perše, et al.
Publicado: (2013) -
Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder
por: Georgi Tosev, et al.
Publicado: (2021)